Beyond Air Dividende 2024

Ko dara Beyond Air?

Beyond Air Inc is a global company specializing in the development and production of medical products. The company was founded in 2011 by Steven Lisi, who is also the current CEO (Chief Executive Officer). History Beyond Air Inc was founded to develop new treatment options for patients with respiratory diseases. The company's focus is on researching and developing technologies that can be used to combat severe lung diseases. In 2014, Beyond Air Inc merged with NitricGen Inc, a provider of nitric oxide systems for the healthcare industry. This merger allowed Beyond Air Inc to expand its portfolio and enhance its offering of medical products. Business Model Beyond Air is a pharmaceutical company focused on respiratory diseases. The company follows a licensing-based business model, licensing its technologies and products to partner licensees to ensure improved marketing and widespread availability of its products. Beyond Air also has its own marketing and sales department, which sells directly to medical facilities. This highlights the need for licenses to support independent distribution in order to make Beyond Air's products accessible everywhere. Divisions Beyond Air operates in two main business areas. The first is the "Medical Grade Nitric Oxide" division, where the company develops novel technologies for the treatment of respiratory diseases. The second is the "Nasal Nitric Oxide" division, which has developed a patented device for nasal breathing enhancement in children. Products One of Beyond Air's key innovations is the medical device LungFit™, which is used directly at the patient's bedside and delivers medical nitric oxide into the airways. LungFit™ is an advanced medical device used for the treatment of patients with severe respiratory diseases such as bronchospasm, COPD (Chronic Obstructive Pulmonary Disease), and ARDS (Acute Respiratory Distress Syndrome). Additionally, Beyond Air also offers a patented nasal breathing device for children. This device increases nasal flow and allows for better breathing in children with colds or allergic upper respiratory tract conditions. Conclusion Beyond Air is a globally operating company focusing on the development of medical products for patients with respiratory diseases. The company follows a licensing-based business model to make its products accessible through partner licensees. Beyond Air offers innovative and advanced medical devices, including the LungFit™ system and a patented nasal breathing device for children. Beyond Air ir viens no populārākajiem uzņēmumiem vietnē Eulerpool.com.